L5P | Venture Creation

Model

Focus

Business Characteristics

Strategy

Our guiding principles and philosophy are to identify and select promising life sciences and medical technologies in newly evolving and defined emerging/niche markets and then use our development and commercialization expertise to create value.  Through a combination of technology identification, outsourcing of preclinical development and operational execution L5P will quickly capitalize the value of portfolio products. More importantly, L5P will seek to retire risk as quickly as possible and will have predefined triggers to eliminate products (i.e. Quick Kill) from the portfolio.  This avoids the trap that most start-ups fall into of continuing to fund a project even if it is doomed to fail.  Additionally, such out sourcing efforts require limited capital expenditures relative to the traditional start-up model (no bricks and mortar), therefore, L5P can develop multiple technologies in parallel. 

• Invest our time, focus and passion by assisting and being directly involved in the management and leadership of all portfolio companies.
• Only invest in marketable ideas that are tractable from a technical, regulatory and manufacturing perspective.
• Develop innovative pathways to commercialization that minimize time and investment to maximize value creation and generate a high ROI.

MODEL

We identify technologies through academia, physicians, innovators, and larger companies that are more than just great science projects and are something that can be quickly commercialized into a high margin product that meets a large unmet need for the public or physicians. We use Level 5 Partners to manage all projects.  We are capital efficient and appropriate capital on moving the technology forward toward commercialization and not on infrastructure or overhead.  Finally, Level 5 Partners does not become emotionally attached to projects regardless of the science, market size or the novelty of the technology.  In short, we are quick to kill a project if the technical issues are too complex or the clinical regulatory path is too burdensome.

FOCUS

• Identify unique market opportunities and technologies from internal, academia, physician and unorthodox sources
• Only invest in marketable ideas that are tractable from a technical, regulatory and manufacturing perspective.
• Develop innovative Pathways to commercialization that minimize time and investment, maximize value creation and generate a high ROI.
• Only invest in technologies that can reach an exit point (commercialization, partnership or licensing) in 36 months or less.

BUSINESS CHARACTERISTICS

L5P capabilities span the continuum from discovery to commercialization.  The following list is just a highlight of what we can offer:

• Clinical/Regulatory strategy and execution
• Identification and development of KOLs and Centers of Excellence
• Market identification and assessment
• Prototype, Design, and Product Development
• Manufacturing and scale-up
• Supply chain optimizatio
• Launch plans
• Global market expansion